| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.04 | 0.5 |